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 CURRENTOPINION Pump the organ: procurement and resuscitation
technologies beyond static cold storage
Henrik Petrowsky
The current section of organ preservation and
procurement focuses on dynamic organ preser-
vation and resuscitation technologies in solid organ
transplantation. Themain goal of this sectionwas to
highlight the latest developments in machine
perfusion technologies in cardiothoracic and
abdominal organ transplantation. Current Opinion
in Organ Transplantation is delighted to present top
reviews from leading international expert groups,
including groups from the United States [1], the
Netherlands [2], Great Britain [3], Switzerland [4],
Canada [5,6], Spain [7], and Australia [8].
Organ perfusion has been already approached
in the beginning of the last century by French
surgeon Axel Carrel who became Nobel laureate
in 1912 for his contribution in vascular suture
techniques and transplantation. At this time, Car-
rel designated his work to the idea of maintaining
organs viable outside the body. After he met
engineer Charles Lindbergh [9], who is known
for the first transatlantic flight in 1927, both sci-
entists developed the perfusion pump, which was a
complex glass apparatus at this time. Using this
technology at normothermic conditions, Carrel
and Lindbergh [10] were able to maintain contrac-
tions of cat hearts for a period of 12h [11]. These
groundbreaking achievements represented the
birth of organ perfusion and appeared to be so
spectacular at this time that both scientists
appeared on the cover page of the TIME magazine
in 1938 [12].
The further development of perfusion systems
for the clinical use in organ transplantation was
marginally driven during the last quarter of the last
century because of the availability of efficient pro-
curement solutions for static cold storage preser-
vation as described by the Milwaukee group in
this section [1]. Static cold storage is an easy
applicable preservation method and remained the
standard preservation over a long period. The
extreme shortage of donor organs and the urgent
need to expand the donor pool by using marginal
and donation after cardiac death (DCD) organs
resulted in a clinical revival of dynamic preservation
methods during the last decade [13]. This has been
also mirrored by the increasing annual number of
publications on this topic (Fig. 1).
Common goals of machine perfusion as
reported by almost all groups in the present section
are: expansion of the donor pool by using marginal
and DCD organs, mitigation of ischemia-reperfu-
sion injury, resuscitation of marginal and DCD
organs, well tolerated prolongation of ‘out of the
body’ time, and rapid assessment of organ function
before implantation to improve graft selection. The
question whether organs should be perfused cold or
warm follows the two main perfusion strategies
of hypothermic versus normothermic perfusion.
The physiologic aspects of temperature-regulated
perfusion have been discussed in detail especially
for kidney and liver by Zimmermann et al. [1].
Currently, machine perfusion in kidney trans-
plantation has achieved the most clinical advance-
ment. The current state of hypothermic and
normothermic machine perfusion in kidney trans-
plantation has been described in this section by
expert groups from Groningen [2] and Cambridge
[3]. Although both strategies have been successfully
evaluated in clinical kidney transplantation, only
hypothermic machine perfusion reached the stage
of completing a randomized controlled trial. The
Groningen group reported that ‘. . .hypothermic
machine perfusion has been proven effective for
all types of deceased donor kidneys; its beneficial
effect was outstanding for extended criteria donor
(ECD) grafts’ [2]. Hypothermic and normothermic
machine perfusion has been evaluated in liver trans-
plantation as well. The concept of hypothermic
oxygenated perfusion as performed by Zurich group
[4] appears an attractive strategy to improve organ
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quality and posttransplant outcome of donation
after brain death (DBD) and DCD livers. This
concept relies on a short endischemic hypothermic
oxygenated perfusion for 1–2h before implan-
tation. But also normothermic and subnormother-
mic machine perfusion appears to be an attractive
strategy in liver transplantation as reported by the
Toronto group in this section [5]. A recently
published phase 1 trial from the Oxford group has
demonstrated safety and feasibility of this technol-
ogy [14]. Whether normothermic or hypothermic
oxygenated perfusion is superior in kidney and liver
transplantation remains to be demonstrated in
the future. Currently, there are ongoing randomized
controlled trials investigating both concepts of
hypothermic and normothermicmachine perfusion
in liver transplantation.
The role of oxygen supply during hypothermic
perfusion has been addressed by various experimen-
tal and clinical studies. Although a direct compari-
son is lacking, De Deken et al. [2] and Schlegel et al.
[4] stated that experimental and clinical studies in
kidney and liver transplantation suggest that
hypothermic perfusion with oxygen supply appears
to be superior to hypothermic perfusion without
oxygen.
Another important concept to procure
controlled or uncontrolled abdominal DCD organs
is advocated by the Barcelona group in this section,
called abdominal regional perfusion [7]. This
perfusion technique applies to the time before organ
retrieval and has been clinically evaluated under
hypothermic and normothermic conditions. The
authors of this review report that normothermic
abdominal regional perfusion is preferred when
retrieval of more than one organ system (e.g., kid-
neys and liver) is targeted. By using this technique,
even uncontrolled abdominal DCD organs can be
successfully resuscitated that might otherwise not
be considered for transplantation.
The beneficial effects of machine perfusion in
abdominal organ transplantation have been also
observed for cardiothoracic organs as reported by
Cypel et al. [6] and McDonald et al. [8] in this
section. Organs with extended criteria or from
DCD donors appear to be associated with
the highest benefit. Although hypothermic
machine perfusion has been evaluated in cardiac
transplantation, McDonald et al. [8] consider nor-
mothermic machine perfusion as the ‘. . .most
promising approach to the successful recovery
and transplantation of hearts from human DCD
donors. . .’. Especially organs, which tolerate less
longer periods of cold ischemia such as the
heart, machine perfusion may offer an effective
strategy that can safely prolong the ‘out of the
body’ time.
In summary, all reviews of the present section
on dynamic organ preservation reflect growing evi-
dence that machine perfusion of abdominal and
cardiothoracic organs is associated with beneficial
effects especially for ECD andDCDorgans. By apply-
ing this technology, organs can be successfully
resuscitated that might be otherwise discarded.
The current and future application of perfusion
systems offers a promising strategy to expand the
donor pool, a strategy that can save many lives on
the waiting list.
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FIGURE 1. Annual number of publications on machine
perfusion. For the period 1995–2015, in total 435
publications were retrieved from PubMed on 1 April 2016
using search [machine perfusion] AND [organ
transplantation].
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